Koers Reata Pharmaceuticals, Inc.
Aandelen
RETA
US75615P1030
Biotechnologie & Medisch Onderzoek
Recentste transcriptie over Reata Pharmaceuticals, Inc.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 01-09-22 |
Director of Finance/CFO | 60 | 26-09-23 | |
John Hunter
IRC | Investor Relations Contact | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 01-09-22 |
Director/Board Member | - | 26-09-23 | |
Michael Dambach
BRD | Director/Board Member | - | 26-09-23 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.10% | 0 M€ | 0,00% | - | |
0.07% | 0 M€ | 0,00% | - | |
0.05% | 773 M€ | -.--% | - | |
0.04% | 509 M€ | -.--% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |